Emerging technologies for cancer therapy using accelerated particles
Cancer therapy with accelerated charged particles is one of the most valuable biomedical
applications of nuclear physics. The technology has vastly evolved in the past 50 years, the …
applications of nuclear physics. The technology has vastly evolved in the past 50 years, the …
The anatomic basis of leptomeningeal metastasis
Leptomeningeal metastasis (LM), or spread of cancer to the cerebrospinal fluid (CSF)–filled
space surrounding the central nervous system, is a fatal complication of cancer. Entry into …
space surrounding the central nervous system, is a fatal complication of cancer. Entry into …
[HTML][HTML] 6th and 7th International consensus guidelines for the management of advanced breast cancer (ABC guidelines 6 and 7)
F Cardoso, S Paluch-Shimon, E Schumacher-Wulf… - The breast, 2024 - Elsevier
This manuscript describes the Advanced Breast Cancer (ABC) international consensus
guidelines updated at the last two ABC international consensus conferences (ABC 6 in …
guidelines updated at the last two ABC international consensus conferences (ABC 6 in …
Hypothyroidism following radiotherapy for head and neck cancer: a systematic review of the literature and opportunities to improve the therapeutic ratio
MK Rooney, LM Andring, KL Corrigan, V Bernard… - Cancers, 2023 - mdpi.com
Simple Summary Hypothyroidism is a common toxicity experienced after radiotherapy for
head and neck malignancies. In this systemic review of the literature, we consolidated the …
head and neck malignancies. In this systemic review of the literature, we consolidated the …
Intrathecal trastuzumab versus alternate routes of delivery for HER2-targeted therapies in patients with HER2+ breast cancer leptomeningeal metastases
Background Patients with HER2+ breast cancer (BC) frequently develop leptomeningeal
metastases (LM). While HER2-targeted therapies have demonstrated efficacy in the …
metastases (LM). While HER2-targeted therapies have demonstrated efficacy in the …
Leptomeningeal metastases in melanoma patients: an update on and future perspectives for diagnosis and treatment
J Steininger, FF Gellrich, K Engellandt… - International journal of …, 2023 - mdpi.com
Leptomeningeal disease (LMD) is a devastating complication of cancer with a particularly
poor prognosis. Among solid tumours, malignant melanoma (MM) has one of the highest …
poor prognosis. Among solid tumours, malignant melanoma (MM) has one of the highest …
Systemic therapy for melanoma brain and leptomeningeal metastases
WJ Sherman, E Romiti, L Michaelides… - … treatment options in …, 2023 - Springer
Opinion statement Melanoma has a high propensity to metastasize to the brain which
portends a poorer prognosis. With advanced radiation techniques and targeted therapies …
portends a poorer prognosis. With advanced radiation techniques and targeted therapies …
Pharmacotherapy for leptomeningeal disease in breast cancer
Clinical data supporting the best therapeutic approach in leptomeningeal disease (LMD;
also known as leptomeningeal metastases or leptomeningeal carcinomatosis) are lacking …
also known as leptomeningeal metastases or leptomeningeal carcinomatosis) are lacking …
Leptomeningeal disease (LMD) in patients with melanoma metastases
Simple Summary Leptomeningeal disease in melanoma (LMM) patients is characterized by
aggressiveness and dismal outcomes. Clinical studies and case reports demonstrate the …
aggressiveness and dismal outcomes. Clinical studies and case reports demonstrate the …
The Spectrum of Headache in Leptomeningeal Metastases: A Comprehensive Review with Clinical Management Guidelines
JA Wilcox, R Estrera, A Boire - Current Pain and Headache Reports, 2023 - Springer
Abstract Purpose of Review Headaches are a common, oftentimes debilitating symptom in
patients with leptomeningeal metastases. Recent Findings The third edition of the …
patients with leptomeningeal metastases. Recent Findings The third edition of the …